Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Oct 7, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-issuer
TL;DR
DRL filed a 6-K on Oct 7, 2024, standard foreign issuer report.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on October 7, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing indicates ongoing reporting requirements for Dr. Reddy's Laboratories as a foreign private issuer, providing transparency to investors about its regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-24-001063 (filing_id) — Accession Number
- 20241007 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer of this document?
The filer is Dr. Reddy's Laboratories Limited.
When was this Form 6-K filed?
This Form 6-K was filed on October 7, 2024.
Where is Dr. Reddy's Laboratories Limited's principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under Form 20-F.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-10-07 06:12:07
Filing Documents
- drr0680_6k.htm (6-K) — 14KB
- drr0680_ex99-1.htm (EX-99.1) — 21KB
- drr0680_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0680_ex99-1img02.jpg (GRAPHIC) — 8KB
- drr0680_ex99-1img03.jpg (GRAPHIC) — 8KB
- drr0680_ex99-1img04.jpg (GRAPHIC) — 8KB
- 0001575872-24-001063.txt ( ) — 79KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 5, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3